Testing effectiveness (Phase 2)Study completedNCT03568136
What this trial is testing
Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis
Who this might be right for
Dermatitis, AtopicEczema, AtopicNeurodermatitis, Atopic
GWT-TUD GmbH 22